Learning the Roles of the Hepatic Adaptive Immune System in Hepatocellular Carcinoma--Nature's Guide for Successful Cancer Immunotherapy

Mathias Heikenwälder*, Eli Pikarsky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The different roles of the adaptive immune system in cancer are beginning to unfold. The dramatic responses to immune check point drugs in some tumors generated an accelerated need for understanding the complex set of interactions between tumor and immune cells. In view of the major pathophysiological role of immune cells in hepatocellular carcinoma, it is not surprising that malignant hepatocytes interact extensively with adaptive immune cells, resulting in both protumor immunopathology and antitumor protective immunity. Identifying potential responders to drugs that target the adaptive immune system, monitoring their immune response to the tumor, and devising the best treatment combinations depends on understanding the complex set of interactions taking place within the tumor and in the adjacent hepatic parenchyma.

Original languageAmerican English
Pages (from-to)210-218
Number of pages9
JournalSeminars in Liver Disease
Volume37
Issue number3
DOIs
StatePublished - 1 Aug 2017

Bibliographical note

Publisher Copyright:
© 2017 by Thieme Medical Publishers, Inc.

Keywords

  • chronic inflammation
  • hepatocellular carcinoma
  • immune checkpoint
  • immunosuppression
  • immunotherapy
  • mouse models

Fingerprint

Dive into the research topics of 'Learning the Roles of the Hepatic Adaptive Immune System in Hepatocellular Carcinoma--Nature's Guide for Successful Cancer Immunotherapy'. Together they form a unique fingerprint.

Cite this